532878 Stock Overview
Alpa Laboratories Limited manufactures and sells pharmaceutical finished dosage forms in India.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Alpa Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹90.62 |
| 52 Week High | ₹115.00 |
| 52 Week Low | ₹55.10 |
| Beta | 0.86 |
| 1 Month Change | 3.00% |
| 3 Month Change | -11.59% |
| 1 Year Change | 46.94% |
| 3 Year Change | 63.43% |
| 5 Year Change | 256.07% |
| Change since IPO | 65.37% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532878 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -2.5% | -2.8% | -1.5% |
| 1Y | 46.9% | 54.9% | 45.0% |
Return vs Industry: 532878 underperformed the Indian Pharmaceuticals industry which returned 54.9% over the past year.
Return vs Market: 532878 exceeded the Indian Market which returned 45% over the past year.
Price Volatility
| 532878 volatility | |
|---|---|
| 532878 Average Weekly Movement | 6.2% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 532878 has not had significant price volatility in the past 3 months.
Volatility Over Time: 532878's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 318 | Paresh Chawla | www.alpalabs.in |
Alpa Laboratories Limited manufactures and sells pharmaceutical finished dosage forms in India. The company offers ethical, generic, and over the counter products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human and veterinary use. It also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations.
Alpa Laboratories Limited Fundamentals Summary
| 532878 fundamental statistics | |
|---|---|
| Market cap | ₹1.90b |
| Earnings (TTM) | ₹178.44m |
| Revenue (TTM) | ₹1.15b |
10.7x
P/E Ratio1.7x
P/S RatioIs 532878 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532878 income statement (TTM) | |
|---|---|
| Revenue | ₹1.15b |
| Cost of Revenue | ₹744.49m |
| Gross Profit | ₹403.61m |
| Other Expenses | ₹225.17m |
| Earnings | ₹178.44m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.48 |
| Gross Margin | 35.15% |
| Net Profit Margin | 15.54% |
| Debt/Equity Ratio | 1.1% |
How did 532878 perform over the long term?
See historical performance and comparison